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We present a case of a 17 year old male who presented with altered mental status and 
worsening hallucinations. Past medical history includes PTSD, ADHD, and pineal gland 
germinoma status post radiofrequency ablation.  
Presentation was remarkable for slow, dysarthric speech, mental disorientation, and 
delayed movements upon simple commands. Otherwise, vitals, baseline labs, imaging 
(Brain MRI), and diagnostics (EEG) were unremarkable.  
A multidisciplinary team decided to initially undergo psychiatric therapeutic intervention, 
focused on benzodiazepines and anti-psychotics, however patient’s status worsened, 
demonstrating catatonia, dystonia, and explosive agitation. Further laboratory 
investigation ruled out electrolyte disturbances, uremia/hepatic encephalopathy, thyroid 
storm, drug overdose/withdrawal, eventually settling on a working diagnosis of catatonic 
depression.  
Given his deteriorating mental status throughout admission and prior oncologic history, a 
lumbar puncture was performed to rule out other causes of encephalopathy, with CSF 
studies remarkable for the presence of NMDA encephalitis autoantibodies, most likely 
sequelae from his existing pineal gland germinoma.  
Anti-NMDA receptor encephalitis is an autoimmune disease associated with antibodies 
against N-methyl-D-aspartate (NDMA) receptors, which control electrical impulses in the 
brain. These autoantibodies can variably be associated with tumors and possibly 
responsive to immunotherapy. Initial treatment consisted of intravenous immunoglobulin 
(IVIG), methylprednisolone and therapeutic plasma exchange. After minimal success, 
patient received rituximab and sirolimus, which resulted in improved psychomotor 
symptoms. 
Diagnosing Anti-NMDA receptor encephalitis can be quite challenging, particularly with 
its variable presentation in the setting of prior psychiatric diagnoses. Classically, Anti-
NMDA receptor encephalitis demonstrates hyperkinetic movements (e.g. dystonia, 
dyskinesia, chorea, seizures); however, catatonic movements do occur, and can be a 
severe and life-threatening state. Being cognizant of the overlapping psychiatric and 
psychomotor symptoms, including catatonic features, can prompt the clinician to suspect 
and rule out Anti-NMDA encephalitis prior to settling on a primary psychiatric diagnosis.  
 
 
 
